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Manuscript
To the Editor,  21 
The results of Demoly et al1 demonstrate promising effects of two doses of 22 
the house dust mite sublingual tablet in allergic rhinitis, with mean 23 
improvements in the primary outcome of the total combined rhinitis score 24 
(TCRS) exceeding the minimal clinically important difference (MCID) of 1.0.  25 
However on inspection of the 95% confidence intervals, it is evident that the 26 
lower bounds for improvements in TCRS were less than the MCID: reported 27 
changes from placebo were 0.45 (6.7% difference) and 0.49 (7.2% difference) 28 
for 6 and 12 SQ-HDM doses respectively, inferring that such responses were 29 
statistically significant but perhaps not so clinically meaningful2.  Pointedly no 30 
clinically relevant improvements were observed in disease specific quality of 31 
life score.  This in turn begs the question as to whether similar improvements 32 
would be seen with SQ-HDM in patients with persistent allergic rhinitis who 33 
were optimally treated with conventional pharmacotherapy. 34 
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